Clinical Trial Update: Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

View source ↗

Summary

A safety-focused clinical trial update describing a study to evaluate the occurrence of essential fatty acid deficiency in pediatric patients with parenteral nu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Fatty Acid Deficiency
• Malnutrition
• Parenteral Nutrition Associated Liver Disease

Drugs mentioned

• Omegaven (fish oil-based intravenous fat emulsion)

Snippet

Sponsor: Fresenius Kabi | Conditions: Parenteral Nutrition Associated Liver Disease (PNALD), Essential Fatty Acid Deficiency | Status: RECRUITING